PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-1000.55
Negative P/E while Healthcare median is -1.31. Seth Klarman would scrutinize path to profitability versus peers.
851.19
P/S exceeding 1.5x Healthcare median of 10.25. Jim Chanos would check for potential multiple compression risks.
135.14
P/B exceeding 1.5x Healthcare median of 2.80. Jim Chanos would check for potential asset write-down risks.
-968.95
Negative FCF while Healthcare median P/FCF is -7.17. Seth Klarman would investigate cash flow improvement potential.
-5171.30
Negative operating cash flow while Healthcare median P/OCF is -0.19. Seth Klarman would investigate operational improvement potential.
135.14
Fair value ratio exceeding 1.5x Healthcare median of 2.80. Jim Chanos would check for valuation bubble risks.
-0.02%
Negative earnings while Healthcare median yield is -0.31%. Seth Klarman would investigate path to profitability.
-0.10%
Negative FCF while Healthcare median yield is -0.28%. Seth Klarman would investigate cash flow improvement potential.